SCHEMBL6399713

SCHEMBL6399713

NC(=O)C1CN(c2ccccc2)C(=O)[N]C1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
GAA P10253 1/20 0.37
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA4 P22748 2/20 0.36
CA6 P23280 2/20 0.36
CA7 P43166 2/20 0.36
CA9 Q16790 2/20 0.36
CA5B Q9Y2D0 2/20 0.36
CA13 Q8N1Q1 1/20 0.36
ALDH1A1 P00352 4/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HSD17B10 Q99714 1/20 0.36
POLB P06746 4/20 0.35
USP2 O75604 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6404673 0.85 POLB (0.41) MEN1KMT2ANPC1RAB9AALDH1A1
SCHEMBL6399373 0.85 KMT2A (0.41) KMT2ANPC1RAB9AGAACA1
SCHEMBL6401079 0.85 HTR1A (0.42) MEN1KMT2ARAB9AGAAALDH1A1
SCHEMBL6401431 0.84 PARP1 (0.44) ALDH1A1HPGDHSD17B10MAPTRIPK2
SCHEMBL6404664 0.84 ALDH1A1 (0.43) MEN1KMT2AALDH1A1POLBMAPT
SCHEMBL6400903 0.80 MAPT (0.46) MEN1KMT2ACA1CA2CA4
SCHEMBL6404663 0.80 KMT2A (0.44) MEN1KMT2AALDH1A1USP2SMN1; SMN2
SCHEMBL6399970 0.80 CRBN (0.40) GAAALDH1A1KDM4EHSD17B10POLB
SCHEMBL6406389 0.75 KMT2A (0.39) MEN1KMT2ANPC1RAB9AGAA
SCHEMBL5104476 0.70 USP30 (0.51) MEN1KMT2ANPC1RAB9ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US claimed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP claimed
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US disclosed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054696-A1 Indole compounds and medicinal use thereof IDO1, GPR119, SLC5A1 MEN1 1510/4885KMT2A 673/4885NPC1 706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.